Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 6Recruiting 3Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Lymphoma 335Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Lymphoma, Large B-Cell, Diffuse 216Lymphoma, Non-Hodgkin 193Lymphoma, Follicular 172Leukemia, Lymphocytic, Chronic, B-Cell 129Lymphoma, B-Cell 123Hodgkin Disease 112Leukemia 104Recurrence 101Lymphoma, Mantle-Cell 89Burkitt Lymphoma 88Lymphoma, T-Cell, Peripheral 60Lymphoma, Extranodal NK-T-Cell 56Multiple Myeloma 54Leukemia, Myeloid, Acute 53Lymphoma, B-Cell, Marginal Zone 51Lymphoma, T-Cell 41Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 39Neoplasms 39Leukemia, B-Cell 39Lymphoma, T-Cell, Cutaneous 37Lymphoma, Large-Cell, Immunoblastic 31Myelodysplastic Syndromes 30Hematologic Neoplasms 25Mycosis Fungoides 24Lymphoma, Large-Cell, Anaplastic 24Neoplasms, Plasma Cell 23Waldenstrom Macroglobulinemia 22Immunoblastic Lymphadenopathy 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Vascular Diseases × Lymphoid × Clear all
NCT04309084 2023-02-16

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Celularity Incorporated

Phase 1 Unknown
29 enrolled
LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Neoplasm, Residual, Hemostatic Disorders, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡